{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T02:10:27Z","timestamp":1780625427954,"version":"3.54.1"},"reference-count":50,"publisher":"Elsevier BV","issue":"5-6","license":[{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1016\/j.neuropharm.2011.06.015","type":"journal-article","created":{"date-parts":[[2011,7,4]],"date-time":"2011-07-04T15:33:28Z","timestamp":1309793608000},"page":"1033-1047","source":"Crossref","is-referenced-by-count":39,"title":["Therapeutic window of opportunity for the neuroprotective effect of valproate versus the competitive AMPA receptor antagonist NS1209 following status epilepticus in rats"],"prefix":"10.1016","volume":"61","author":[{"given":"Melanie","family":"Langer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Brandt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Zellinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"L\u00f6scher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2011.06.015_bib1","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0079-6123(07)63001-5","article-title":"The dentate gyrus: fundamental neuroanatomical organization (dentate gyrus for dummies)","volume":"163","author":"Amaral","year":"2007","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.neuropharm.2011.06.015_bib2","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1385\/MN:32:2:173","article-title":"Mood stabilizers target cellular plasticity and resilience cascades: implications for the development of novel therapeutics","volume":"32","author":"Bachmann","year":"2005","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neuropharm.2011.06.015_bib3","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1124\/jpet.106.102491","article-title":"Valproic acid is not a substrate for P-glycoprotein or multidrug resistance proteins 1 and 2 in a number of in\u00a0vitro and in\u00a0vivo transport assays","volume":"320","author":"Baltes","year":"2007","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2011.06.015_bib4","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.eplepsyres.2008.07.007","article-title":"Resistance to antiepileptic drugs and expression of P-glycoprotein in two rat models of status epilepticus","volume":"82","author":"Bankstahl","year":"2008","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.neuropharm.2011.06.015_bib5","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.nbd.2008.01.005","article-title":"Antiepileptic drug resistant rats differ from drug responsive rats in GABAA-receptor subunit expression in a model of temporal lobe epilepsy","volume":"31","author":"Bethmann","year":"2008","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2011.06.015_bib6","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1212\/WNL.51.1.41","article-title":"Comparison of valproate and phenobarbital treatment after status epilepticus in rats","volume":"51","author":"Bolanos","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.neuropharm.2011.06.015_bib7","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0920-1211(03)00114-1","article-title":"Epileptogenesis and neuropathology after different types of status epilepticus induced by prolonged electrical stimulation of the basolateral amygdala in rats","volume":"55","author":"Brandt","year":"2003","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.neuropharm.2011.06.015_bib8","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.neuropharm.2006.05.021","article-title":"Treatment with valproate after status epilepticus: effect on neuronal damage, epileptogenesis, and behavioral alterations in rats","volume":"51","author":"Brandt","year":"2006","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2011.06.015_bib9","doi-asserted-by":"crossref","first-page":"8602","DOI":"10.1523\/JNEUROSCI.0633-10.2010","article-title":"Disease-modifying effects of phenobarbital and the NKCC1 inhibitor bumetanide in the pilocarpine model of temporal lobe epilepsy","volume":"30","author":"Brandt","year":"2010","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2011.06.015_bib10","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/(SICI)1096-9861(19970901)385:3<385::AID-CNE4>3.0.CO;2-#","article-title":"Neuron loss, granule cell axon reorganization, and functional changes in the dentate gyrus of epileptic kainate-treated rats","volume":"385","author":"Buckmaster","year":"1997","journal-title":"J.\u00a0Comp. Neurol."},{"key":"10.1016\/j.neuropharm.2011.06.015_bib11","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/00019052-200104000-00009","article-title":"The process of epileptogenesis: a pathophysiological approach","volume":"14","author":"Dalby","year":"2001","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.neuropharm.2011.06.015_bib12","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/S0028-3908(02)00215-0","article-title":"Regulation of Akt and glycogen synthase kinase-3 beta phosphorylation by sodium valproate and lithium","volume":"43","author":"De Sarno","year":"2002","journal-title":"Neuropharmacology"},{"issue":"Suppl. 2","key":"10.1016\/j.neuropharm.2011.06.015_bib13","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1528-1167.2008.02009.x","article-title":"Posttraumatic epilepsy: the challenge of translating discoveries in the laboratory to pathways to a cure","volume":"50","author":"Dichter","year":"2009","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuropharm.2011.06.015_bib14","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/S0079-6123(07)63041-6","article-title":"Epileptogenesis in the dentate gyrus: a critical perspective","volume":"163","author":"Dudek","year":"2007","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.neuropharm.2011.06.015_bib15","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/j.1528-1157.1991.tb05627.x","article-title":"Alterations in the renal excretion of valproate and its metabolites after chronic treatment","volume":"32","author":"Fisher","year":"1991","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuropharm.2011.06.015_bib16","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1111\/j.1528-1157.2000.tb00283.x","article-title":"Status epilepticus-induced neuronal loss in humans without systemic complications or epilepsy","volume":"41","author":"Fujikawa","year":"2000","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuropharm.2011.06.015_bib17","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/S0006-8993(98)01202-5","article-title":"Mossy cells in the mouse dentate gyrus: identification in the dorsal hilus and their distribution along the dorsoventral axis","volume":"816","author":"Fujise","year":"1999","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2011.06.015_bib18","doi-asserted-by":"crossref","first-page":"7052","DOI":"10.1523\/JNEUROSCI.20-18-07052.2000","article-title":"Deficit of striatal parvalbumin-reactive GABAergic interneurons and decreased basal ganglia output in a genetic rodent model of idiopathic paroxysmal dystonia","volume":"20","author":"Gernert","year":"2000","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2011.06.015_bib19","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1046\/j.1460-9568.2001.01428.x","article-title":"Progression of spontaneous seizures after status epilepticus is associated with mossy fibre sprouting and extensive bilateral loss of hilar parvalbumin and somatostatin-immunoreactive neurons","volume":"13","author":"Gorter","year":"2001","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2011.06.015_bib20","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0079-6123(07)63013-1","article-title":"Interneurons of the dentate gyrus: an overview of cell types, terminal fields and neurochemical identity","volume":"163","author":"Houser","year":"2007","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.neuropharm.2011.06.015_bib21","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.yebeh.2009.02.036","article-title":"Curing epilepsy: progress and future directions","volume":"14","author":"Jacobs","year":"2009","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.neuropharm.2011.06.015_bib22","doi-asserted-by":"crossref","first-page":"5967","DOI":"10.1523\/JNEUROSCI.0110-07.2007","article-title":"Epigenetic modulation of seizure-induced neurogenesis and cognitive decline","volume":"27","author":"Jessberger","year":"2007","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2011.06.015_bib23","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s00424-010-0809-1","article-title":"Glutamate receptors, neurotoxicity and neurodegeneration","volume":"460","author":"Lau","year":"2010","journal-title":"Pflugers Arch."},{"key":"10.1016\/j.neuropharm.2011.06.015_bib24","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/S0022-3565(25)22759-8","article-title":"Valproic acid in amygdala-kindled rats: alterations in anticonvulsant efficacy, adverse effects and drug and metabolite levels in various brain regions during chronic treatment","volume":"250","author":"L\u00f6scher","year":"1989","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2011.06.015_bib25","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1111\/j.1528-1157.1995.tb01637.x","article-title":"Comparison of anticonvulsant efficacy of valproate during prolonged treatment with one and three daily doses or continuous (\u201ccontrolled release\u201d) administration in a model of generalized seizures in rats","volume":"36","author":"L\u00f6scher","year":"1995","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuropharm.2011.06.015_bib26","doi-asserted-by":"crossref","first-page":"669","DOI":"10.2165\/00023210-200216100-00003","article-title":"Basic pharmacology of valproate: a review after 35 years of clinical use for the treatment of epilepsy","volume":"16","author":"L\u00f6scher","year":"2002","journal-title":"CNS Drugs"},{"key":"10.1016\/j.neuropharm.2011.06.015_bib27","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1111\/j.1528-1167.2007.01093.x","article-title":"The pharmacokinetics of antiepileptic drugs in rats: consequences for maintaining effective drug levels during prolonged drug administration in rat models of epilepsy","volume":"48","author":"L\u00f6scher","year":"2007","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuropharm.2011.06.015_bib28","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1124\/pr.110.003046","article-title":"Prevention or modification of epileptogenesis after brain insults: experimental approaches and translational research","volume":"62","author":"L\u00f6scher","year":"2010","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.neuropharm.2011.06.015_bib29","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1097\/00004647-200209000-00006","article-title":"Grey matter and white matter ischemic damage is reduced by the competitive AMPA receptor antagonist, SPD 502","volume":"22","author":"McCracken","year":"2002","journal-title":"J.\u00a0Cereb. Blood Flow Metab."},{"key":"10.1016\/j.neuropharm.2011.06.015_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pneurobio.2004.03.009","article-title":"Kindling and status epilepticus models of epilepsy: rewiring the brain","volume":"73","author":"Morimoto","year":"2004","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neuropharm.2011.06.015_bib31","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1016\/S0022-3565(24)38297-7","article-title":"SPD 502: a water-soluble and in\u00a0vivo long-lasting AMPA antagonist with neuroprotective activity","volume":"289","author":"Nielsen","year":"1999","journal-title":"J\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2011.06.015_bib32","series-title":"The Rat Brain in Stereotaxic Coordinates","author":"Paxinos","year":"2007"},{"key":"10.1016\/j.neuropharm.2011.06.015_bib33","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0079-6123(02)35008-8","article-title":"Progression of neuronal damage after status epilepticus and during spontaneous seizures in a rat model of temporal lobe epilepsy","volume":"135","author":"Pitk\u00e4nen","year":"2002","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.neuropharm.2011.06.015_bib34","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.eplepsyres.2006.12.004","article-title":"Effect of novel AMPA antagonist, NS1209, on status epilepticus. An experimental study in rat","volume":"74","author":"Pitk\u00e4nen","year":"2007","journal-title":"Epilepsy Res."},{"issue":"Suppl. 1","key":"10.1016\/j.neuropharm.2011.06.015_bib35","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.yebeh.2008.09.023","article-title":"Molecular and cellular basis of epileptogenesis in symptomatic epilepsy","volume":"14","author":"Pitk\u00e4nen","year":"2009","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.neuropharm.2011.06.015_bib36","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/0013-4694(72)90177-0","article-title":"Modification of seizure activity by electrical stimulation: II. Motor seizure","volume":"32","author":"Racine","year":"1972","journal-title":"Electroencephalogr. Clin. Neurophysiol."},{"key":"10.1016\/j.neuropharm.2011.06.015_bib37","series-title":"The Dentate Gyrus and Its Role in Seizures","author":"Ribak","year":"1992"},{"key":"10.1016\/j.neuropharm.2011.06.015_bib38","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/nm1074","article-title":"The neurobiology of antiepileptic drugs for the treatment of nonepileptic conditions","volume":"10","author":"Rogawski","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.neuropharm.2011.06.015_bib39","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1007\/s00018-007-7079-x","article-title":"The mechanisms of action of valproate in neuropsychiatric disorders: can we see the forest for the trees? CELL MOL","volume":"64","author":"Rosenberg","year":"2007","journal-title":"Life Sci."},{"key":"10.1016\/j.neuropharm.2011.06.015_bib40","series-title":"The Dentate Gyrus and Its Role in Seizures","first-page":"93","article-title":"Differentiation of rat dentate neurons by morphology and electrophysiology in hippocampal sclices: granule cells, spiny hilar cells and aspiny \u201cfast-spiking\u201d cells","author":"Scharfman","year":"1992"},{"key":"10.1016\/j.neuropharm.2011.06.015_bib41","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/hipo.450010106","article-title":"Permanently altered hippocampal structure, excitability, and inhibition after experimental status epilepticus in the rat: the \u201cdormant basket cell\u201d hypothesis and its possible relevance to temporal lobe epilepsy","volume":"1","author":"Sloviter","year":"1991","journal-title":"Hippocampus"},{"key":"10.1016\/j.neuropharm.2011.06.015_bib42","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1002\/ana.410350604","article-title":"The functional organization of the hippocampal dentate gyrus and its relevance to the pathogenesis of temporal lobe epilepsy","volume":"35","author":"Sloviter","year":"1994","journal-title":"Ann. Neurol."},{"issue":"Suppl. 4","key":"10.1016\/j.neuropharm.2011.06.015_bib43","first-page":"29","article-title":"Hippocampal pathology and pathophysiology in temporal lobe epilepsy","volume":"11","author":"Sloviter","year":"1996","journal-title":"Neurologia"},{"key":"10.1016\/j.neuropharm.2011.06.015_bib44","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/cne.10630","article-title":"\u201cDormant basket cell\u201d hypothesis revisited: relative vulnerabilities of dentate gyrus mossy cells and inhibitory interneurons after hippocampal status epilepticus in the rat","volume":"459","author":"Sloviter","year":"2003","journal-title":"J.\u00a0Comp. Neurol."},{"issue":"Suppl. 9","key":"10.1016\/j.neuropharm.2011.06.015_bib45","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.1528-1167.2008.01931.x","article-title":"Hippocampal epileptogenesis in animal models of mesial temporal lobe epilepsy with hippocampal sclerosis: the importance of the \u201clatent period\u201d and other concepts","volume":"49","author":"Sloviter","year":"2008","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuropharm.2011.06.015_bib46","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.molbrainres.2004.11.011","article-title":"Valproic acid, but not lamotrigine, suppresses seizure-induced c-fos and c-Jun mRNA expression","volume":"135","author":"Szot","year":"2005","journal-title":"Brain Res. Mol. Brain Res."},{"issue":"Suppl. 2","key":"10.1016\/j.neuropharm.2011.06.015_bib47","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.1528-1167.2008.02005.x","article-title":"Preventing and treating posttraumatic seizures: the human experience","volume":"50","author":"Temkin","year":"2009","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuropharm.2011.06.015_bib48","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1054\/jocn.2002.1133","article-title":"Valproate and neuroprotection","volume":"9","author":"Vajda","year":"2002","journal-title":"J\u00a0Clin. Neurosci."},{"key":"10.1016\/j.neuropharm.2011.06.015_bib49","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.expneurol.2004.01.016","article-title":"Progression of temporal lobe epilepsy in the rat is associated with immunocytochemical changes in inhibitory interneurons in specific regions of the hippocampal formation","volume":"187","author":"van Vliet","year":"2004","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuropharm.2011.06.015_bib50","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.nbd.2005.09.006","article-title":"Antiepileptic drug resistant rats differ from drug responsive rats in hippocampal neurodegeneration and GABAA-receptor ligand-binding in a model of temporal lobe epilepsy","volume":"21","author":"Volk","year":"2006","journal-title":"Neurobiol. Dis."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390811002590?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390811002590?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T22:47:44Z","timestamp":1741301264000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390811002590"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10]]},"references-count":50,"journal-issue":{"issue":"5-6","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["S0028390811002590"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2011.06.015","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2011,10]]}}}